Researchers looking to buy BPC-157 for laboratory investigation have made it one of the most searched research peptides globally. BPC-157 — Body Protective Compound 157 — is a synthetic pentadecapeptide derived from a protein found in gastric juice, studied extensively in preclinical models for its effects on tissue repair, angiogenesis, and gastrointestinal protection. EdgeChems supplies BPC-157 for sale as an HPLC-verified liquid research compound at ≥98% purity, with a third-party Certificate of Analysis on every batch.
What Is BPC-157?
BPC-157 is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) first isolated from human gastric juice. Its full systematic name is Body Protective Compound 157, reflecting its origin in research on mucosal protective factors. Unlike many peptides derived from pituitary or hypothalamic sources, BPC-157 was identified from the gastrointestinal tract, which has informed decades of research into its cytoprotective and tissue-healing properties in controlled laboratory settings.
The peptide is water-stable and does not require refrigeration-sensitive reconstitution in the same way as many lyophilized growth hormone secretagogues. It is typically studied as an aqueous solution at concentrations ranging from 200 mcg/mL to 500 mcg/mL in in vitro and animal model experiments.
Mechanisms of Action — What the Research Shows
BPC-157 has been investigated across multiple mechanistic pathways in peer-reviewed preclinical literature:
- Nitric Oxide (NO) pathway modulation: Studies in rodent models suggest BPC-157 activates the NO-generating system, which is implicated in vasodilation, wound healing, and cytoprotection in mucosal tissue.
- Growth factor upregulation: In vitro and in vivo studies have observed upregulation of VEGF (Vascular Endothelial Growth Factor), EGF receptor expression, and other angiogenic factors in BPC-157-treated tissue models.
- Tendon and ligament fibroblast activation: Controlled studies on cultured tendon fibroblasts show BPC-157 increases cell migration and proliferation — effects relevant to tendon repair research models.
- Gastrointestinal cytoprotection: Multiple studies demonstrate protective effects on the gastric mucosa against NSAID-induced injury, alcohol toxicity, and stress ulceration in rodent models. This is one of BPC-157’s most replicated research findings.
- Dopaminergic and serotonergic interaction: Neurological research models have examined BPC-157 for interactions with dopamine and serotonin systems, including modulation of receptor sensitivity in specific brain region studies.
BPC-157 in Tissue Repair Research
One of the most prominent areas of BPC-157 research involves musculoskeletal tissue models. Studies published in peer-reviewed journals including the Journal of Physiology–Paris and European Journal of Pharmacology have examined BPC-157 in animal models of tendon transection, bone fracture, and muscle crush injury. Findings consistently show accelerated histological healing markers compared to vehicle controls — though all results are from animal or cell culture studies and have not been replicated in human clinical trials.
For researchers studying tendon-to-bone healing, BPC-157 is frequently investigated alongside TB-500 (Thymosin Beta-4) for potential synergistic effects on actin polymerization and tissue remodelling. EdgeChems also offers a pre-formulated BPC-157 + TB-500 Blend for researchers studying these complementary pathways in a single preparation.
BPC-157 vs BPC-157 Arginate
A common question among researchers is the difference between standard BPC-157 and BPC-157 Arginate (also called BPC-157 stable salt). The arginate form is a salt complex of BPC-157 with arginine, developed to improve stability in physiological pH environments. In research contexts, the arginate form is hypothesized to maintain bioactivity across a broader pH range — relevant to gastrointestinal mucosal studies where acidic conditions may degrade the standard peptide. The two forms are studied for overlapping but not identical applications in preclinical research.
Product Specifications — Buy BPC-157 From EdgeChems
EdgeChems supplies research-grade BPC-157 for sale with the following specifications:
- Format: Liquid solution
- Purity: ≥98% (third-party HPLC verified)
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- CAS Number: 137525-51-0
- Molecular Weight: 1419.5 g/mol
- Storage: -20°C, protected from light
- Stability: 24 months sealed; 30 days once reconstituted
Every batch of BPC-157 sold by EdgeChems ships with a Certificate of Analysis from an independent third-party laboratory. Researchers can request COA documentation before or with every order. Order BPC-157 for sale from EdgeChems here.
Research Applications Summary
BPC-157 is studied for the following preclinical research applications:
- Gastrointestinal mucosal cytoprotection models
- Tendon and ligament repair signalling studies
- Angiogenesis and wound healing research
- Neurological receptor modulation investigations
- Bone healing and fracture repair models
- NSAID-induced organ injury protection studies
Frequently Asked Questions
Is BPC-157 approved for human use? No. BPC-157 is a research compound only, not approved by the FDA or any regulatory body for human or veterinary therapeutic use. It is sold exclusively for in vitro and controlled laboratory research.
What concentration is BPC-157 supplied at? EdgeChems supplies BPC-157 as a liquid solution. Specific concentration details are listed on the product page.
Can BPC-157 be combined with other peptides? In research contexts, BPC-157 has been studied alongside TB-500 and other tissue repair compounds. See EdgeChems’ BPC-157 + TB-500 Blend for a pre-formulated dual-peptide research option.
For research purposes only. Not intended for human or veterinary use. All information is presented for scientific reference.